Abstract Topics

​Diagnosis

  • Cytomorphology
  • Flow cytometry
  • Molecular aberrations (cytogenetic, genetic, gene expression)


Epidemiology

Health Economics & Outcome Research

  • Cost of care
  • Patient-reported outcomes
  • Efficacy outcome measures

MDS Biology and Pathogenesis

  • Normal, MDS, and leukemic stem cells
  • Clonal diversity & evolution
  • MDS Mouse models (GEMMS, PDX)
  • Somatic mutations
  • Spliceosome machinery
  • Gene expression profiling
  • Epigenetic deregulation
  • Immune deregulation
  • Microenvironment and stem cell niche 

Nurses Program (For Poster Presentation Only)

Prognosis

  • Prognostic factors of outcome and risk assessment
  • Predictive factors of response to treatment 

Singular Entities/Subtypes

  • ARCH, CCUS, ICUS
  • MDS in childhood
  • Hereditary MDS including predisposition syndromes
  • MDS with ring sideroblasts
  • Chronic myelomonocytic leukemia and overlap syndromes (MDS/MPN)
  • MDS with deletion 5q
  • Treatment-related MDS 

Treatment

  • Current treatment options
    • Hypomethylating agents
    • Lenalidomide
    • Hematopoietic growth factors
    • Immunosuppressive therapy
  • New developments
    • Preclinical studies
    • Phase I studies
  • Clinical trials
    • Phase II-III
  • Allogeneic hematopoietic cell transplantation
    • Bridging to transplantation
    • Post-transplantation treatment 
  • Supportive care, including iron overload
  • Quality of life

Keep Me Updated